Madelyn A. Gillentine,Tianyun Wang,Kendra Hoekzema,Jill Rosenfeld,Pengfei Liu,Hui Guo,Chang N. Kim,Bert B. A. De Vries,Lisenka E. L. M. Vissers,Magnus Nordenskjold,Malin Kvarnung,Anna Lindstrand,Ann Nordgren,Jozef Gecz,Maria Iascone,Anna Cereda,Agnese Scatigno,Silvia Maitz,Ginevra Zanni,Enrico Bertini,Christiane Zweier,Sarah Schuhmann,Antje Wiesener,Micah Pepper,Heena Panjwani,Erin Torti,Farida Abid,Irina Anselm,Siddharth Srivastava,Paldeep Atwal,Carlos A. Bacino,Gifty Bhat,Katherine Cobian,Lynne M. Bird,Jennifer Friedman,Meredith S. Wright,Bert Callewaert,Florence Petit,Sophie Mathieu,Alexandra Afenjar,Celenie K. Christensen,Kerry M. White,Orly Elpeleg,Itai Berger,Edward J. Espineli,Christina Fagerberg,Charlotte Brasch-Andersen,Lars Kjærsgaard Hansen,Timothy Feyma,Susan Hughes,Isabelle Thiffault,Bonnie Sullivan,Shuang Yan,Kory Keller,Boris Keren,Cyril Mignot,Frank Kooy,Marije Meuwissen,Alice Basinger,Mary Kukolich,Meredith Philips,Lucia Ortega,Margaret Drummond-Borg,Mathilde Lauridsen,Kristina Sorensen,Anna Lehman,Elena Lopez-Rangel,Paul Levy,Davor Lessel,Timothy Lotze,Suneeta Madan-Khetarpal,Jessica Sebastian,Jodie Vento,Divya Vats,L. Manace Benman,Shane Mckee,Ghayda M. Mirzaa,Candace Muss,John Pappas,Hilde Peeters,Corrado Romano,Maurizio Elia,Ornella Galesi,Marleen E. H. Simon,Koen L. I. van Gassen,Kara Simpson,Robert Stratton,Sabeen Syed,Julien Thevenon,Irene Valenzuela Palafoll,Antonio Vitobello,Marie Bournez,Laurence Faivre,Kun Xia,John Acampado,Rachel K. Earl,Tomasz Nowakowski,Raphael A. Bernier,Evan E. Eichler

Abstract:Background With the increasing number of genomic sequencing studies, hundreds of genes have been implicated in neurodevelopmental disorders (NDDs). The rate of gene discovery far outpaces our understanding of genotype–phenotype correlations, with clinical characterization remaining a bottleneck for understanding NDDs. Most disease-associated Mendelian genes are members of gene families, and we hypothesize that those with related molecular function share clinical presentations. Methods We tested our hypothesis by considering gene families that have multiple members with an enrichment of de novo variants among NDDs, as determined by previous meta-analyses. One of these gene families is the heterogeneous nuclear ribonucleoproteins (hnRNPs), which has 33 members, five of which have been recently identified as NDD genes ( HNRNPK , HNRNPU , HNRNPH1 , HNRNPH2 , and HNRNPR ) and two of which have significant enrichment in our previous meta-analysis of probands with NDDs ( HNRNPU and SYNCRIP ). Utilizing protein homology, mutation analyses, gene expression analyses, and phenotypic characterization, we provide evidence for variation in 12 HNRNP genes as candidates for NDDs. Seven are potentially novel while the remaining genes in the family likely do not significantly contribute to NDD risk. Results We report 119 new NDD cases (64 de novo variants) through sequencing and international collaborations and combined with published clinical case reports. We consider 235 cases with gene-disruptive single-nucleotide variants or indels and 15 cases with small copy number variants. Three hnRNP-encoding genes reach nominal or exome-wide significance for de novo variant enrichment, while nine are candidates for pathogenic mutations. Comparison of HNRNP gene expression shows a pattern consistent with a role in cerebral cortical development with enriched expression among radial glial progenitors. Clinical assessment of probands ( n = 188–221) expands the phenotypes associated with HNRNP rare variants, and phenotypes associated with variation in the HNRNP genes distinguishes them as a subgroup of NDDs. Conclusions Overall, our novel approach of exploiting gene families in NDDs identifies new HNRNP -related disorders, expands the phenotypes of known HNRNP -related disorders, strongly implicates disruption of the hnRNPs as a whole in NDDs, and supports that NDD subtypes likely have shared molecular pathogenesis. To date, this is the first study to identify novel genetic disorders based on the presence of disorders in related genes. We also perform the first phenotypic analyses focusing on related genes. Finally, we show that radial glial expression of these genes is likely critical during neurodevelopment. This is important for diagnostics, as well as developing strategies to best study these genes for the development of therapeutics.

A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders

cis-Regulatory Chromatin Contacts in Neural Cells Reveal Contributions of Genetic Variants to Complex Neurological Disorders

Gene identification for ocular congenital cranial motor neuron disorders using human sequencing, zebrafish screening, and protein binding microarrays

Mapping cis -regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes

Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders

Inferring causal cell types of human diseases and risk variants from candidate regulatory elements

Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs

Single cell variant to enhancer to gene map for coronary artery disease

Functional categorization of gene regulatory variants that cause Mendelian conditions

Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease

RNA variant assessment using transactivation and transdifferentiation

A novel framework for functional annotation of variants of uncertain significance in ID/ASD risk gene CC2D1A

Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

BRAIN-MAGNET: A novel functional genomics atlas coupled with convolutional neural networks facilitates clinical interpretation of disease relevant variants in non-coding regulatory elements

Defining the function of disease variants with CRISPR editing and multimodal single cell sequencing

variants in the non-coding spliceosomal snRNA gene are a frequent cause of syndromic neurodevelopmental disorders

Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics

Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders

Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles

Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases

Leveraging base-pair mammalian constraint to understand genetic variation and human disease